notificationsアラート設定

アブストラクト

Title [集中治療室での薬の使い方] 抗真菌薬
Subtitle 特集 エキスパートが直伝! 敗血症の薬学的管理 最新版
Authors 小坂篤志
Authors (kana)
Organization 東京都立墨東病院感染症科
Journal 月刊薬事
Volume 63
Number 9
Page 1752-1759
Year/Month 2021 / 7
Article 報告
Publisher じほう
Abstract [Points] ●侵襲性カンジダ症の診療は漏れがないようバンドルに準じてマネジメントを行う. ●抗真菌薬はCandida属菌の真菌種同定と薬剤感受性, 組織移行性を考慮して選択する. ●臨床データが少ないが, ECMO使用中の患者では抗真菌薬の血中濃度低下に注意が必要である.
Practice 薬学
Keywords
  • 全文ダウンロード： 従量制、基本料金制の方共に764円(税込) です。
download全文ダウンロード(1.11MB)

参考文献

  • 1) 深在性真菌症のガイドライン作成委員会・編 : 深在性真菌症の診断・治療ガイドライン2014, 協和企画, 2014
  • 2) Kobayashi T, et al : Impact of infectious disease consultation in patients with candidemia: a retrospective study, systematic literature review, and meta-analysis. Open Forum Infect Dis, 7 : ofaa270, 2020
    pubmed
  • 3) Clancy CJ, et al : Diagnosing invasive candidiasis. J Clin Microbiol, 56 : e01909-01917, 2018
    pubmed
  • 4) Clancy CJ, et al : Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis, 56 : 1284-1292, 2013
    pubmed
  • 5) Westh H, et al : Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect, 15 : 544-551, 2009
    pubmed
残りの30件を表示する
  • 6) Dark P, et al : Accuracy of LightCycler(R) SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review and meta-analysis. Intensive Care Med, 41 : 21-33, 2015
    pubmed
  • 7) Kakeya H, et al : National Trends in the distribution of candida species causing candidemia in Japan from 2003 to 2014. Med Mycol J, 59 : E19-E22, 2018
    pubmed
  • 8) Rodriguez-Adrian LJ, et al : Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology. Medicine(Baltimore), 82 : 187-202, 2003
    pubmed
  • 9) Oude Lashof AM, et al : Ocular manifestations of candidemia. Clin Infect Dis, 53 : 262-268, 2011
    pubmed
  • 10) Nagao M, et al : Clinical characteristics and risk factors of ocular candidiasis. Diagn Microbiol Infect Dis, 73 : 149-152, 2012
    pubmed
  • 11) Bassetti M, et al : A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med, 41 : 1601-1610, 2015
  • 12) Tissot F, et al : β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med, 188 : 1100-1109, 2013
  • 13) Yan T, et al : Appropriate source control and antifungal therapy are associated with improved survival in critically ill surgical patients with intra-abdominal candidiasis. world J Surg, 44 : 1459-1469, 2020
    pubmed
  • 14) Moore EC, et al : Candida in burns: risk factors and outcomes. J Burn Care Res, 31 : 257-263, 2010
    pubmed
  • 15) Pfaller MA, et al : Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp. Diagn Microbiol Infect Dis, 79 : 198-204, 2014
    pubmed
  • 16) Kuse ER, et al : Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet, 369 : 1519-1527, 2007
    pubmed
  • 17) Clinical and Laboratory Standards Institute : Reference method for broth dilution antifungal susceptibility testing of yeasts: Third informational supplement M27-S3. Clinical and Laboratory Standards Institute, 2008
  • 18) Bae JH, et al : Intravitreal liposomal amphotericin B for treatment of endogenous candida endophthalmitis. Jpn J Ophthalmol, 59 : 346-352, 2015
    pubmed
  • 19) Pappas PG, et al : Clinical practice guideline for the manage-ment of candidiasis: 2016 update by the infectious diseases society of america. Clin Infect Dis, 62 : e1-e50, 2016
  • 20) Andes D, et al : Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob Agents Chemother, 53 : 24-34, 2009
    pubmed
  • 21) Lestner J, et al : Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections. Expert Opin Drug Metab Toxicol, 9 : 911-926, 2013
    pubmed
  • 22) Pappas PG, et al : Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis, 45 : 883-893, 2007
    pubmed
  • 23) More-Duarte J, et al : Comparison of caspofungin and amphotericin B for invasive candidiasis. N Eng J Med, 347 : 2020-2029, 2002
  • 24) Roden MM, et al : Triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics. Clin Infect Dis, 36 : 1213-1220, 2003
    pubmed
  • 25) Baddley JW, et al : Antifungal combination therapy: clinical potential. Drugs, 65 : 1461-1480, 2005
    pubmed
  • 26) Abele-Horn M, et al : A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic candida infections in intensive care patients. Infection, 24 : 426-432, 1996
    pubmed
  • 27) Kiser TH, et al : Evaluation of sulfobutylether-β-cyclodextrin(SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy. Crit Care, 19 : 32, 2015
  • 28) Heinemann V, et al : Pharmacokinetics of liposomal amphotericin B(Ambisome) in critically ill patients. Antimicrob Agent Chemother, 41 : 1275-1280, 1997
  • 29) Mehta NM, et al : Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment. Intensive Care Med, 33 : 1018-1024, 2007
  • 30) Shekar K, et al : Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study. Crit Care, 19 : 164, 2015
  • 31) Watt KM, et al : Antifungal Extraction by the extracorporeal membrane oxygenation circuit. J Extra Corpor Technol, 49 : 150-159, 2017
    pubmed
  • 32) Foulquier JB, et al : Liposomal amphotericin B pharmaco-kinetics in a patient treated with extracorporeal membrane oxygenation. Med Mal Infect, 49 : 69-71, 2019
  • 33) Zhao Y, et al : Altered pharmacokinetics and dosing of liposomal amphotericin B and isavuconazole during extra-corporeal membrane oxygenation. pharmacotherapy, 40 : 89-95, 2020
  • 34) Cavayas YA, et al : Fungal infections in adult patients on extracorporeal life support. Crit Care, 22 : 98, 2018
    pubmed
  • 35) de Roux Q, et al : candida bloodstream infection under veno-arterial ECMO therapy. Crit Care, 23 : 314, 2019
    pubmed
はじめての方へ
個人／法人会員登録のご案内